China-Based Contract Research Organization Selects Oracle Cloud to Optimize Clinical Trial Data Management

 Fountain Medical Development (FMD), a full-service Contract Research Organization (CRO) headquartered in Beijing, China, and its US affiliate, FMD K&L, have adopted Oracle’s cloud-based clinical data management solutions, to increase operational efficiencies and speed time to market. The solutions deliver increased productivity to the company’s drug development process, reduce overall costs, improve communications with its sponsors, and advance clinical study quality and speed, worldwide. 

FMD was able to retire its aging, antiquated, legacy system and migrate to a more cost-effective cloud-based environment with Oracle Health Sciences InForm and Oracle Siebel Clinical Trial Management System (CTMS). The new, unified, technology platform has enhanced capabilities in data management, study planning and design, trial operations, analytics, and patient engagement. 

“We are committed to delivering innovative solutions to our sponsors. This is why FMD decided to work with Oracle,” said Dr. Henry Wu, CEO, Fountain Medical Development. “Oracle’s data management solutions will enable us to improve our data quality, advance our trial data management efficiencies, reduce costs, and gain a deeper understanding of our clinical trial data across FMD’s integrated enterprise globally.” 

Fountain Medical Development is a leading CRO offering a full range of International Conference on Harmonization Good Clinical Practice (ICH GCP) compliant clinical research services for multinational clients conducting clinical research in China. As one of the fastest growing clinical CROs in East Asia and China, FMD has established 12 operational offices throughout China, Hong Kong, Taiwan, Japan, Korea, the United States, and Armenia, with a strong focus on data management and biostatistics. 

By moving to Oracle Health Sciences InForm and Oracle Siebel CTMS), FMD will gain powerful analytics capabilities that will provide a faster and better understanding of its clinical trial data across its locations, saving the company time and effort. 

“Clinical research is becoming more complex and holistic by the day, and contract researchers are challenged to provide more services than ever before. Oracle Health Sciences provides global contract research organizations, like FMD, with an integrated platform and advanced analytics tools to help CROs and their sponsors find the cures of tomorrow,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. 

FMD is a member of the Oracle CRO Advantage Program, an initiative that helps drive CRO success with Oracle Health Sciences products through training, sales and marketing support, and bi-directional communication on Oracle products and strategy.